Nir Eyal

InstitutionRutgers University
AddressNew
Jersey
vCardDownload vCard
    Publication Timeline
    COVID-19 publications
    Bar chart showing 17 Covid-19 publications, with a maximum of 4 publications in July 2020
    All Publications
    Bar chart showing 73 publications over 13 distinct years, with a maximum of 11 publications in 2020
    These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.

    To see the data from both graphs as text, click here.
    Publication Field Summary
    This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.
    Publication List
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
    Sort By:     Newest   |   Oldest   |   Most Cited   |   Most Discussed
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Eyal N, Lipsitch M. How to Test Severe Acute Respiratory Syndrome Coronavirus 2 Vaccines Ethically Even After One Is Available. Clin Infect Dis. 2021 12 16; 73(12):2332-2334. PMID: 33639622.
      Citations: 1     Fields:    Translation:Humans
    2. Eyal N, Gerhard T. Do coronavirus vaccine challenge trials have a distinctive generalisability problem? J Med Ethics. 2021 Jun 07. PMID: 34099541.
      Citations:    Fields:    
    3. Lee K, Eyal N. COVID-19 controlled human infection studies: worries about local community impact and demands for local engagement. J Med Ethics. 2021 08; 47(8):539-542. PMID: 33980657.
      Citations: 1     Fields:    Translation:HumansPHPublic Health
    4. Eyal N, Gerhard T, Strom BL. Strengthening and accelerating SARS-CoV-2 vaccine safety surveillance through registered pre-approval rollout after challenge tests. Vaccine. 2021 06 11; 39(26):3455-3458. PMID: 34023137.
      Citations:    Fields:    Translation:Humans
    5. Steuwer B, Jamrozik E, Eyal N. Prioritizing second-generation SARS-CoV-2 vaccines through low-dosage challenge studies. Int J Infect Dis. 2021 Apr; 105:307-311. PMID: 33592338.
      Citations: 4     Fields:    Translation:Humans
    6. Eyal N, Lipsitch M. Testing SARS-CoV-2 vaccine efficacy through deliberate natural viral exposure. Clin Microbiol Infect. 2021 Mar; 27(3):372-377. PMID: 33421580.
      Citations: 2     Fields:    Translation:Humans
    7. Broockman D, Kalla J, Guerrero A, Budolfson M, Eyal N, Jewell NP, Magalhaes M, Sekhon JS. Broad cross-national public support for accelerated COVID-19 vaccine trial designs. Vaccine. 2021 01 08; 39(2):309-316. PMID: 33334616.
      Citations: 2     Fields:    Translation:HumansPHPublic Health
    8. Eyal N, Halkitis PN. AIDS Activism and Coronavirus Vaccine Challenge Trials. AIDS Behav. 2020 12; 24(12):3302-3305. PMID: 32591984.
      Citations: 4     Fields:    
    9. Eyal N, Lipsitch M, Smith PG. Reply to Hasford and to Spinola et al. J Infect Dis. 2020 10 01; 222(9):1574-1575. PMID: 32845306.
      Citations:    Fields:    Translation:HumansCellsPHPublic Health
    10. Eyal N, Lipsitch M. Opinion: It's ethical to test promising coronavirus vaccines against less-promising ones. Proc Natl Acad Sci U S A. 2020 08 11; 117(32):18898-18901. PMID: 32699147.
      Citations:    Fields:    Translation:HumansPHPublic Health
    11. Steel R, Buchak L, Eyal N. Why continuing uncertainties are no reason to postpone challenge trials for coronavirus vaccines. J Med Ethics. 2020 12; 46(12):808-812. PMID: 32661074.
      Citations: 4     Fields:    Translation:HumansPHPublic Health
    12. Eyal N. Unnecessary hesitancy on human vaccine tests. Science. 2020 07 10; 369(6500):150-151. PMID: 32646991.
      Citations: 1     Fields:    Translation:HumansCellsPHPublic Health
    13. Eyal N, Lipsitch M, Smith PG. Response to Dawson et al. J Infect Dis. 2020 07 06; 222(3):516-517. PMID: 32495823.
      Citations: 1     Fields:    Translation:HumansCellsPHPublic Health
    14. Eyal N, Lipsitch M, Smith PG. Response to Cioffi. J Infect Dis. 2020 06 16; 222(1):169-170. PMID: 32348499.
      Citations: 5     Fields:    Translation:HumansCells
    15. Eyal N. Why Challenge Trials of SARS-CoV-2 Vaccines Could Be Ethical Despite Risk of Severe Adverse Events. Ethics Hum Res. 2020 Jul; 42(4):24-34. PMID: 32441894.
      Citations: 5     Fields:    Translation:HumansCellsPHPublic Health
    16. Eyal N, Lipsitch M, Smith PG. Human Challenge Studies to Accelerate Coronavirus Vaccine Licensure. J Infect Dis. 2020 05 11; 221(11):1752-1756. PMID: 32232474.
      Citations: 72     Fields:    Translation:HumansCellsPHPublic Health
    17. Firth P, Eyal N. Allocating Medical Resources in the Time of Covid-19. N Engl J Med. 2020 05 28; 382(22):e79. PMID: 32343501.
      Citations: 1     Fields:    Translation:CellsPHPublic Health
    Eyal's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (114)
    Explore
    _
    Co-Authors (28)
    Explore
    _
    Similar People (60)
    Explore
    _